Testing for hypertrophic cardiomyopathy is primarily recommended for individuals with a first-degree relative diagnosed with the condition, as well as for people experiencing symptoms like chest pain, ...
Hypertrophic cardiomyopathy (HCM) is considered a hereditary autosomal dominant condition, but genetic testing is positive in only half of patients. In patients with negative genetic tests, the ...
Please provide your email address to receive an email when new articles are posted on . Rare and common genetic variants contribute substantially to susceptibility to hypertrophic cardiomyopathy in ...
Cytokinetics has launched EARTH-HCM, an interactive online tool aimed at improving awareness and understanding of hypertrophic cardiomyopathy (HCM) in the U.S. Developed with input from prominent ...
Interactive Tool Harnesses Real-World Data to Visualize Burden of Disease in HCM and Advance Equitable Access to Care SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, ...
Hypertrophic cardiomyopathy (HCM) is a long-term genetic condition that thickens the heart muscle and reduces blood flow. Early diagnosis can lower risks like sudden cardiac death, heart failure, and ...
SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the launch of EARTH-HCM (Epidemiology, Awareness, Real-world Treatment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results